The FORTE clinical trial of carfilzomib in multiple myeloma
Gareth Morgan, MD, FRCP, FRCPath, PhD from the University of Arkansas for Medical Sciences, Arkansas, AR discusses the results of clinical trial of carfilzomib, lenalidomide, cyclophosphamide and dexa... Author: VJHemOnc Added: 02/29/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 29, 2016 Category: Cancer & Oncology Source Type: podcasts

Phase II Study Results: Ixazomib Maintenance Response After Ixazomib-Lenalidomide-Dexa.
At ASH 2014, Dr. Shaji Kumar discussed his abstract titled Long-Term Ixazomib Maintenance Is Tolerable and Improves Depth of Response Following Ixazomib-Lenalidomide-Dexameth​asone Induction in Patient... Author: feeds Added: 04/15/2015 (Source: Oncology Tube)
Source: Oncology Tube - April 15, 2015 Category: Cancer & Oncology Source Type: podcasts